NewGenIvf Group (NASDAQ:NIVF) Shares to Reverse Split on Monday, July 6th

Posted by Brenda Bartman on Jul 2nd, 2026

Shares of NewGenIvf Group Limited (NASDAQ:NIVF – Free Report) are going to reverse split on Monday, July 6th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, July 5th.

NewGenIvf Group Trading Down 16.4%

Shares of NewGenIvf Group stock traded down $0.09 during trading hours on Thursday, reaching $0.46. 876,271 shares of the company’s stock were exchanged, compared to its average volume of 11,033,116. The business has a fifty day moving average of $0.97 and a two-hundred day moving average of $3.34. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98. NewGenIvf Group has a 1 year low of $0.43 and a 1 year high of $295.17.

NewGenIvf Group (NASDAQ:NIVF – Get Free Report) last issued its earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The firm had revenue of $1.42 million for the quarter. Equities research analysts predict that NewGenIvf Group will post 4.74 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, NewGenIvf Group presently has an average rating of “Sell”.

Check Out Our Latest Report on NewGenIvf Group

Insider Transactions at NewGenIvf Group

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 85,317 shares of the company’s stock in a transaction on Wednesday, May 27th. The stock was sold at an average price of $0.80, for a total value of $68,253.60. Following the completion of the sale, the insider directly owned 54,561 shares in the company, valued at $43,648.80. This represents a 60.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 31.80% of the stock is currently owned by insiders.

About NewGenIvf Group

(Get Free Report)

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.